Denis Chem Lab

Denis Chem Lab EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Denis Chem Lab (537536.BO) as of Oct 22, 2026 is 26.03. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 6.62 — a change of 293.23% (higher).

EV/OCF

26.03

YoY

293.23%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Denis Chem Lab is 2025 26.03 . EV/OCF (Enterprise Value to Operating Cash Flow) of Denis Chem Lab was 2024 6.62 . It decreases by 293.23% higher compared to the previous year.

The Denis Chem Lab EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
14.99 INR
Jan 1, 2019
8.48 INR
Jan 1, 2020
13.96 INR
Jan 1, 2021
5.84 INR
Jan 1, 2022
5.52 INR
Jan 1, 2023
4.65 INR
Jan 1, 2024
6.62 INR
Jan 1, 2025
26.03 INR
The Denis Chem Lab EV/OCF history
YEAREV/OCFYoY
26.03+293.23%
6.62+42.29%
4.65-15.74%
5.52-5.44%
5.84-58.17%
13.96+64.60%
8.48-43.44%
14.99+37.12%
10.94-43.77%
19.45+190.68%
6.69-112.29%
-54.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Denis Chem Lab Stock analysis

What does Denis Chem Lab do? Denis Chem Lab Ltd. generates revenue through the manufacture and sale of transfusion solutions in bottles, including sterile intravenous injectables for human and veterinary use. The company offers a range of products such as carbohydrate solutions, sodium chloride solutions, potassium chloride solutions, and plasma volume expanders under its own brands. It also produces sterile intravenous injectables in volumes from 100 milliliters to 10 liters for direct sales to customers. Additionally, the firm manufactures contract products for multinational pharmaceutical companies, leveraging its facility for third-party production. The company's primary customers include healthcare providers and veterinary institutions that require sterile intravenous solutions. Its product portfolio targets both human and veterinary markets, with offerings like antibiotic solutions and dialysis solutions catering to specific medical needs. The firm's contract manufacturing services provide an additional revenue stream by supplying multinational pharmaceutical companies with custom-produced sterile injectables. Denis Chem Lab Ltd. focuses on manufacturing and selling its own branded products, such as carbohydrate in sodium chloride solutions and multi electrolyte solutions, while also engaging in contract manufacturing for multinational pharmaceutical companies. The company's production capabilities span from small-volume solutions to large 10-liter bottles, ensuring versatility in meeting diverse customer demands across healthcare and veterinary sectors. Denis Chem Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Denis Chem Lab stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Denis Chem Lab is 26.03 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Denis Chem Lab changed from 6.62 to 26.03, representing a 293.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Denis Chem Lab since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Denis Chem Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Denis Chem Lab

All Key Metrics — Denis Chem Lab